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Thiol groups can undergo numerous modifications, making cysteine a unique molecular
switch. Cysteine plays structural and regulatory roles as part of proteins or glutathione,
contributing to maintain redox homeostasis and regulate signaling within and amongst
cells. Not surprisingly therefore, cysteines are associated with many hereditary and
acquired diseases. Mutations in the primary protein sequence (gain or loss of a cysteine)
are most frequent in membrane and secretory proteins, correlating with the key roles of
disulfide bonds. On the contrary, in the cytosol and nucleus, aberrant post-translational
oxidative modifications of thiol groups, reflecting redox changes in the surrounding
environment, are a more frequent cause of dysregulation of protein function. This essay
highlights the regulatory functions performed by protein cysteine residues and provides
a framework for understanding how mutation and/or (in)activation of this key amino acid
can cause disease.
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INTRODUCTION
Amino acids are much more than mere building blocks of proteins: their different chemical
properties dictate the catalytic activity of enzymes, protein half-life and a plethora of different
post-translational modifications that govern protein function. This essay concentrates on the
role of cysteine, a thiol containing amino acid that can participate in a variety of chemical
reactions such as post-translational oxidative modifications. Many of them are reversible at
physiological conditions, thereby allowing cysteine to act as a powerful molecular switch, akin to
protein phosphorylation-dephosphorylation cycles. Hence, cysteine modifications are not limited
to the well-known structural role of disulfide bonds in proteins synthesized in the endoplasmic
reticulum (ER), but participate in fundamental intra- and inter-cellular signaling pathways. The
downside of the pleiotropic reactivity of cysteines resides is their high susceptibility to undesired
activation/inactivation in conditions of redox disequilibrium (either oxidative or reductive stress).
Abbreviations: AATD, Alpha-1-antitrypsin deficiency; BiP, Immunoglobulin heavy chain-binding protein;
CFTR, Cystic fibrosis transmembrane conductance regulator; CXCR4, C-X-C chemokine receptor type 4;
ER, Endoplasmic reticulum; ERAD, ER associated degradation; Ero1, Endoplasmic reticulum oxidoreductin
1; Gpx, Glutathione peroxidase; GR, Glutathione reductase; Grx, Glutaredoxin; GSH/GSSG, Reduced/oxidized
glutathione; HMGB1, High mobility group protein B1; KEAP1, Kelch-like ECH-associated protein 1; MD2,
Lymphocyte antigen 96; Nrf2, Nuclear factor erythroid 2-related factor 2; PDI, Protein disulfide isomerase; Prx,
Peroxiredoxin; PTEN, Phosphatase and tensin homolog; QSOX,Quiescin sulfhydryl oxidase; RAGE/ARGE, Advanced
glycosylation end product-specific receptor; ROS, Reactive oxygen species; SOD1, Superoxide Dismutase 1; TLR4,
Toll-like receptor 4; TNF, Tumor necrosis factor; TNFR, TNF receptors; Trx, Thioredoxin; TrxR, Thioredoxin
reductase; VkOR, Vitamin K epoxide reductase.
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In many genetic diseases and cancer, mutations can either
directly target a cysteine or affect residues that contribute to
maintain optimal cysteine pKa, accessibility and/or reactivity.
Here we briefly discuss redoxstasis in cell
compartments and provide examples of disease—associated
modifications/mutations of key cysteine residues.
CYSTEINES REACTIVITY AND REDOX
HOMEOSTASIS
Redox reactions involve the gain (reduction) or loss (oxidation)
of electrons in the reacting compounds. From its reduced form
(SH), the sulfur atom of a cysteine residue can undergo a
wide-range of oxidative modifications (Figure 1). Reactivity is
greatly enhanced for cysteines whose thiol side chain is in
the thiolate form, i.e., deprotonated at physiological pH (S−),
and is influenced by structural factors (Ferrer-Sueta et al.,
2011). Disulfide bonds stabilize the tertiary and/or quaternary
structures of many proteins. They also serve as regulatory
functional switches, a prototype being the activation of the
bacterial transcription factor OxyR in response to oxidative
stress (Zheng et al., 1998; Jo et al., 2015). Progressive cysteine
oxidation by H2O2 leads to cysteine sulfenylation (SOH),
sulfinylation (SO2H) and sulfonylation (SO3H). Among these,
oxidation to SO3H is regarded as irreversible. S-sulfydration
(also called persulfidation) can occur after reactions between
derivatives of hydrogen sulfide (H2S) and thiols (Mishanina et al.,
2015). Reactive nitrogen species (RNS) like nitric oxide (NO)
react with some cysteines causing S-nitrosylation/nitrosation
(Evangelista et al., 2013). Cysteines can also undergo lipid
modifications including palmitoylation and prenylation or bind
metals such as Zn, Fe and Cu. This latter property is crucial
for formation of zinc fingers and iron-sulfur clusters (Oteiza,
2012; Rouault, 2015). Owing to their nucleophilic properties,
thiolate groups also participate in non-redox reactions as in
the catalytic groups of cysteine-proteases and ubiquitin ligases.
For a detailed discussion on cysteine reactivity, its chemotypes
and the methods for their detection, we refer to excellent
reviews (Nagy, 2013; Paulsen and Carroll, 2013; Go et al.,
2015).
Cysteine thiols are key players in conditions of oxidative
stress. Most non-protein antioxidants as well as antioxidant
enzymes are thiol based. Glutathione (GSH, γ-L-Glutamyl-L-
cysteinylglycine) acts as a redox buffer and a cofactor of many
enzymes including glutathione peroxidases (Gpx) that scavenge
peroxides generating oxidized glutathione (GSSG). In humans,
there are eight Gpxs, localized in different compartments
(Brigelius-Flohé and Maiorino, 2013; Figure 2). Other key
peroxide scavengers are peroxiredoxins (Prx; Perkins et al.,
2015). Of the six human Prxs, two are localized in mitochondria
and one in the ER. Thioredoxins (Trx) and glutaredoxins (Grx)
reduce oxidized protein thiols. Oxidized Trx and Grx are reduced
by Trx reductases (TrxR) and GSH, respectively (Holmgren,
1979; Mustacich and Powis, 2000; Fernandes and Holmgren,
2004). Glutathione reductase (GR) is also a key player for redox
homeostasis, replenishing the GSH pool at the expense of GSSG.
It is important to stress that both GR and TrxR rely on the
NADPH/NADP system for their activity, thus establishing a
link between the nicotinamide and thiol redox systems (Jones
and Sies, 2015). Another important player is sulfiredoxin-1,
an ATP-dependent enzyme capable of reducing sulfinylated
proteins (Biteau et al., 2003; Mishra et al., 2015).
REDOX COMPARTMENTALIZATION
The organelles of eukaryotic cells can differ dramatically with
respect to the redox poise of their various redox couples
(Figure 2). The chemistry of primordial cells evolved in
an oxygen-free atmosphere, and cytosolic and mitochondrial
cysteines tend to remain in the reduced states (Go et al., 2015).
Incidentally, this is why most cell-free protocols that recapitulate
nuclear or cytoplasmic reactions include the addition of DTT or
other reductants to work efficiently. In vivo, the establishment
of stable disulfide bonds in these compartments is extremely
unfavorable because of the combined reducing power of GSH,
Grxs and Trxs.
However, there are places where disulfide bonds need
to be inserted into selected proteins. For example, the
Mia40/Erv1 relay allows formation of disulfide bonds in proteins
and their import into the inter-membrane mitochondrial space,
where the low Grx pool kinetically favor this process (Mesecke
et al., 2005; Kojer et al., 2015; Erdogan and Riemer, 2017).
The redox couples present in organelles of the exocytic
pathway display redox poises similar to the extracellular space.
In the ER, nascent membrane and secretory proteins form
disulfide bonds, preparing for their adult life in the oxidizing
extracellular environments. Thus, oxidative power is needed
in the ER, but redox conditions must be tightly controlled to
allow isomerization or reduction of non-native disulfides. The
occurrence of opposite reactions is guaranteed by protein relays
capable of selectively inserting or removing disulfides (Fassio and
Sitia, 2002; Hagiwara and Nagata, 2012). Oxidative folding is
catalyzed by enzymes of the protein disulfide isomerase (PDI)
superfamily, which receive oxidative power from oxidases like
endoplasmic reticulum oxidoreductin 1 (Ero1) and quiescin
sulfhydryl oxidase (QSOX; Bulleid and Ellgaard, 2011; Hudson
et al., 2015). The human genome encodes for numerous PDI-like
enzymes whose activity largely depends on the number of
Trx-like domains and the redox potential of their CXXC motifs
(Hatahet and Ruddock, 2009; Okumura et al., 2015). Depending
on the surrounding redox and ionic conditions, oxidoreductases
may oxidize, isomerize or reduce disulfides. In this wide range
of activities, ERdJ5 is most suited for reducing disulfides (Dong
et al., 2008; Ushioda et al., 2008). TrxR and import of cytosolic
GSH have been proposed as reducing powers to prevent ER
hyperoxidation (Molteni et al., 2004; Appenzeller-Herzog, 2011;
Poet et al., 2017).
Disulfide interactions with PDI-like enzymes provide key
quality control of the secretome, preventing the release of
immature proteins. For instance, ERp44, captures proteins
with exposed thiols and redox-active enzymes lacking suitable
ER localization signals (e.g., Ero1, Prx4, Sumf1), retrieving
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FIGURE 1 | Main post-translational modifications of cysteines. Intermolecular disulfide bonds can be formed with another protein or low molecular weight thiols (like
glutathione). In general, intramolecular bonds are inserted into a reduced protein by disulfide exchange with oxidized glutathione (GSSG) or another oxidized protein
(e.g., Protein disulfide isomerase, PDI), through the formation of mixed disulfides. Oxidation by reactive oxygen species (ROS) initially leads to sulfenylation (SOH).
Because of its relative instability, sulfenylated cysteine can promote intramolecular disulfide bond formation or additionally react with ROS leading first to sulfinylation
(SO2H) and then to sulfonylation (SO3H). While SO2H can be reversed through the catalytic activity of the cytoplasmic enzyme sulfiredoxin-1 (SRXN-1; Biteau et al.,
2003), SO3H is so far considered irreversible. Palmitoylation can also take place through creation of thioester bonds between palmitate and cysteine (Fukata and
Fukata, 2010).
them to the ER (Vavassori et al., 2013; Anelli et al.,
2015).
CYSTEINES AS REDOX MOLECULAR
SWITCHES
Mechanisms ensuring tight redoxstasis control are present in the
three cellular compartments where protein folding takes place
(cytosol, ER and mitochondria) and they are intimately linked
to protein quality control (Anelli et al., 2015). However, cells
additionally exploit cysteine reactivity for purposes other than
oxidative protein folding, namely as switches regulating signaling
and adaptive responses.
A prototypic example is provided by the Nuclear factor
erythroid 2-related factor 2 (Nrf2), a transcription factor
whose nuclear translocation is prevented by interactions with
Kelch-like ECH-associating protein 1 (Keap1). Upon oxidation,
Keap1 dissociates from Nrf2, which can reach the nucleus and
promote transcription of antioxidant response genes (Dinkova-
Kostova et al., 2002). Recently, unexpected links between Nrf2,
redox and ER stress emerged. Ire1 is a transmembrane protein
that initiates the unfolded protein response upon accumulation
of misfolded proteins in the ER lumen. Upon oxidative stress,
Ire1 is sulfenylated and activates the Nrf2 pathway, abandoning
its canonical ER stress sensing function (Hourihan et al., 2016).
Thus, a subtle cysteine modification can shift the pathway to
which a signal transducer is affiliated.
Redox modifications also play key roles in regulating protein
tyrosine phosphorylation. Cysteine oxidative modifications
such as SOH, disulfide formation and S-nitrosylation inhibit
phosphatase and tensin homolog (PTEN) and other protein
tyrosine phosphatases by interfering for example with their
cysteine-dependent catalytic activity (Numajiri et al., 2011;
Corcoran and Cotter, 2013; Pulido, 2015). As an example
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FIGURE 2 | Cellular compartments differ in their redox poise. The left part of the figure summarizes the data available in the literature concerning glutathione redox
potential values (Eh GSSG) in intra- and extra-cellular compartments. Depending on the cell types, physiological conditions and methods used, the results can vary
rather significantly. There remains no doubt, however, that mitochondria and cytosol are far more reducing than the endoplasmic reticulum (ER) and extracellular
space. Noteworthy, Thioredoxin 1 (Trx1) and Trx2 display a more reducing Kox, confirming their pivotal role in maintaining a suitable redox in the cytosol. Owing to
the permeability of nuclear pores, the nucleus is likely to have values similar to the cytosol (values are from Gutscher et al., 2008; Jones and Go, 2010; Kojer et al.,
2012; Birk et al., 2013; Kirstein et al., 2015). The right part highlights instead the main redox control systems in the cytosol, mitochondria and ER. Note the presence
in the ER of proteins promoting formation of disulfide bonds (endoplasmic reticulum oxidoreductin 1 (Ero1), quiescin sulfhydryl oxidase (QSOX), PDI, ERp44, etc.)
and also the absence of Glutathione reductase (GR), thus contributing to higher GSSG/GSH ratios in the ER compared to the cytosol.
of physiological importance, abolishing this rheostat circuit
dampens B lymphocyte activation and antibody production
(Bertolotti et al., 2016). Moreover, a growing body of evidence
supports the redox regulation of several tyrosine kinases, as
described for c-Src (Giannoni and Chiarugi, 2014) and Janus
kinase 2 (JAK2; Smith et al., 2012).
High mobility group protein B1 (HMGB1) is a DNA-binding
nuclear protein that can be released by stressed cells. In
the extracellular space, HMGB1 mediates inflammation or
tissue repair, according to its redox state. If fully reduced,
it binds to Advanced glycation end product-specific receptor
(RAGE) and C-X-C chemokine receptor type 4 (CXCR4) and
activates cell migration and autophagy. Upon formation of an
intramolecular disulfide bond, HMGB1 binds Toll-like receptor
4 (TLR4)/MD-2 receptors complex and stimulates cytokine
secretion. Sulphonylation then inactivates HMGB1, highlighting
how a protein switches function depending on its cysteine redox
state (Fiuza et al., 2003; Venereau et al., 2012; Vénéreau et al.,
2015). Oxidation of a conserved cysteine residue also modulate
the permeability of aquaporin 8 by reversibly inhibiting the
transport of H2O2 andH2O across themembrane of stressed cells
(Medraño-Fernandez et al., 2016).
Another example of redox-based functional re-targeting
aimed to prevent protein aggregation is the induction of holdase
activity in the ER chaperone Immunoglobulin heavy chain-
binding protein (BiP) by cysteine oxidation (Wei et al., 2012;
Wang et al., 2014). Similarly, Prx sulphinylation promotes
formation of homo-oligomers endowed with chaperone activity
(Jang et al., 2004; Hanzén et al., 2016).
Thus, cysteine modifications are key in many intra-
and inter-cellular signaling and adaptive pathways. The
sub-compartmental organization of redoxstasis, based on
spatially constrained protein relays (Woo et al., 2010), and
the low diffusibility of small redox active compounds such as
H2O2 (Bienert and Chaumont, 2014) can explain how redox-
dependent signals can propagate in the presence of powerful
antioxidant systems.
CYSTEINES AND DISEASES
Secretory Proteins
Owing to the importance of structural and regulatory disulfide
bonds in membrane and secretory proteins, mutations in
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luminal cysteines generally have dramatic consequences. Hence,
acquisition or loss of a cysteine often causes retention of the
mutated protein in the ER by thiol-mediated mechanisms (Anelli
et al., 2015), with consequent loss or gain of function. The
difficulty in forming the proper array of disulfide bonds in the
cysteine-rich domains of many membrane receptors can lead
to ER retention and degradation (loss of function), but also
gain of function by interchain disulfide bonding that chronically
activates signal transduction. An astonishing example comes
from type 2A multiple endocrine neoplasia (MEN2A). This
severe condition is often due to mutations in the cysteine-rich
luminal portion of a tyrosine kinase receptor, RET, with strong
genotype-phenotype correlations. The oncogenic hit is the
formation of ligand-independent, covalent homodimers that
constitutively deliver growth signals (Asai et al., 1995; Mulligan,
2014). RETmalfunction can also lead to congenital abnormalities
characterized by failure of neuroblast migration and defective
maturation of the enteric nervous system (Hirschsprung disease),
a condition that in some families coexisted with MEN2A
(Takahashi et al., 1999; Frank-Raue et al., 2011).
Many genetic diseases are caused by gain or loss of a
cysteine in secretory or membrane proteins. Aberrant thiol-
mediated interactions via unpaired cysteines can directly
provoke ER retention and aggregation besides misfolding.
In Pelizaeus-Merzbacher disease, a myelination defect, a
subgroup of mutations affecting the extracellular loop of the
PLP/DM20 protein impair formation of intramolecular disulfide
bridges and cause abnormal protein cross-links, ER retention
and oligodendrocyte death (Dhaunchak et al., 2011). Similar
mechanisms have been demonstrated in some forms of autism
(Comoletti et al., 2004), color blindness (Patel et al., 2005) and
von Willebrand disease (Wang et al., 2012).
Mutations of uromodulin, causing medullary cystic kidney
disease/familial juvenile hyperuricemic nephropathy most often
affect one of the 48 conserved cysteine residues (Rampoldi et al.,
2003; Scolari et al., 2015). Cysteine mutations and aberrant
disulfide bonding underlie the pathogenesis of CD40 deficiency
(Lanzi et al., 2010), TNFR1-associated periodic fever syndrome
(Lobito et al., 2006) and MiDY insulin-deficient diabetes (Liu
et al., 2010). Mutations causing conformational alterations
of alpha-1-antitrypsin make its only cysteine more prone to
form aberrant disulfide bonds in the ER, thus facilitating the
intracellular retention and polymerization of alpha-1-antitrypsin
in Alpha-1-antitrypsin deficiency (AATD; Ronzoni et al., 2016).
Marinesco-Sjogren is a syndrome causing ataxia, intellectual
disability and muscle weakness. This rare disease is caused by
mutations in Sil1, a cofactor of BiP (Anttonen et al., 2005; Krieger
et al., 2013). In yeast recovering from stress, Sil1 reduces oxidized
Kar2, the paralog of human BiP, restoring its normal foldase
activity (Siegenthaler et al., 2017). It remains to be seen whether
and how mutations in Marinesco-Sjogren patients also impact
the reductase function of Sil1.
Cytosolic and Nuclear Proteins
In cytosolic proteins, cysteines can be direct targets of mutations,
but more frequently they are dysregulated or inactivated
by oxidative stress or other environmental conditions. Both
mechanisms have been shown in Parkinson’s disease (PD).
Parkin (PARK2) is an E3 ubiquitin ligase whose dysfunction
causes accumulation of protein aggregates, endangering
dopaminergic neurons (Charan and LaVoie, 2015). Parkin
is highly expressed in the brain and frequently mutated in
autosomal recessive juvenile PD (Biskup et al., 2008). These
mutations often affect cysteines, causing loss of function and
decreased stability of the enzyme (Wang et al., 2005; Seirafi
et al., 2015). Parkin can also be inactivated by S-nitrosylation or
sulphonylation (Chung et al., 2004; Meng et al., 2011). Recent
studies describe interesting interplays between parkin oxidative
modifications, its role in mitochondrial quality control and PD
onset (Zhang et al., 2016). In dopaminergic neurodegenerative
disorders, a key pathogenetic event is also the inactivation of
tyrosine hydroxylase, a rate-limiting enzyme in dopamine and
norepinephrine biosynthesis, by oxidative injury (Di Giovanni
et al., 2012).
Mutations of the antioxidant superoxide dismutase gene
(SOD1) are linked to about one fifth of the cases of familial
amyotrophic lateral sclerosis, a degenerative disorder of
motor neurons. Wild type SOD1 is a covalent disulfide-
linked homodimer localized in part in the mitochondrial
intermembrane space. Pathogenic SOD1 mutants form
high molecular weight oligomers, inducing mitochondrial
dysfunctions (Ferri et al., 2006; Magrané et al., 2009).
Noteworthy, intermolecular disulfide cross-links and
glutathionylation enhance mutant SOD1 aggregation (Cozzolino
et al., 2008; Redler et al., 2011; McAlary et al., 2013), cysteine
111 being a key residue (Valle and Carrì, 2017).
In addition, Alzheimer’s disease (AD) is associated with thiol
modifications, in particular S-nitrosylation. NO is produced
in the brain by neuronal NO synthase (nNOS) and serves
as a key second messenger for instance, regulating neuronal
plasticity and survival (Nakamura and Lipton, 2016; Chong et al.,
2017). However, aberrant S-nitrosylation of proteins such as
PDI and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
can occur in AD (Uehara et al., 2006; Zhao et al., 2015).
S-nitrosylation of GAPDH enhances its binding to the ubiquitin
ligase Siah1. GAPDH/Siah1 complexes accumulate in the nucleus
triggering neuronal apoptosis via excessive protein degradation
and trans-nitrosylation signaling cascades (Hara et al., 2005; Sen
and Snyder, 2011; Nakamura and Lipton, 2013).
Numerous examples of ‘‘gain of cysteine’’ mutations are found
in cancer, p53, KRAS and other oncogenes being preferred
targets. The acquired cysteines cause decreased stability or
impaired DNA binding of the tumor suppressor p53, while
KRAS oncogenes are constitutively activated. Noteworthy, such
acquired cysteines are potential targets for antitumor treatments
(Visscher et al., 2016).
CONCLUDING REMARKS
The multiple chemical reactions of cysteines and their
reversibility in physiological conditions make them ideal
tuneable devices for regulating protein function. Indeed,
evolution has increasingly exploited the regulatory potential
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of cysteine chemistry as atmospheric oxygen became more
abundant and complex multicellular organisms evolved. The
frequency and conservation of this amino acid is indeed higher
in mammals (>2% of the proteome) than in prokaryotes
(0.5%). The examples provided in this essay reveal the
pathophysiological relevance of cysteine redox modifications
in the different compartments of human cells. Disulfide bonds
prevail in the exocytic and endocytic compartments, organelles
which are in direct contact with the oxidizing extracellular
environment. These covalent bonds increase protein stability,
facilitate quality control (Medraño-Fernandez et al., 2014)
and underlie the functional regulation of many secreted
proteins. A wider range of modifications acts in the cytosol and
mitochondria, whose chemistry reflects their origin in an oxygen
free atmosphere. Cysteine residues in these compartments
are largely found in the reduced thiol/thiolate state, which
permits regulation of protein function and activity by way
of a wide-range of oxidative post-translational modifications.
The redox gradients that form within and amongst cells hence
provide ample opportunities to regulate signaling, transcription
and other key biological processes. The price we pay is the
many diseases caused by cysteine mutations or oxidative
deregulation. Novel reagents (Chen et al., 2013; Kim et al.,
2015; Bilan and Belousov, 2016; Wagener et al., 2016) are being
developed to better understand cysteine modifications and
their links with disease, ultimately offering ample practical
exploitations (Nakamura and Lipton, 2016; Wani and Murray,
2017).
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